Patrick Hwu: The graduation program for the 2024 cohort of Moffitt Cancer Center’s Leadership Academy

Patrick Hwu shared a post on LinkedIn:

”Last week, I has the pleasure of attending the graduation program for the 2024 cohort of Moffitt Cancer Center’s Leadership Academy! It was an honor to hear from this talented group as they showcased their innovative projects and officially completed the program.

I’m excited to see how their leadership will shape the future of Moffitt and have a meaningful impact on our patients, organization and the Tampa Bay community.

Please join me in congratulating the 2024 Moffitt Leadership Academy graduates!”

Source: Patrick Hwu/LinkedIn

Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.